Drug Master Files for: olsalazine sodium
✉ Email this page to a colleague
olsalazine sodium Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
17677 | A | II | 9/13/2004 | DOTTIKON EXCLUSIVE SYNTHESIS AG | OLSALAZINE SODIUM |
21633 | I | II | 5/19/2008 | EMCURE PHARMACEUTICALS LTD | OLSALAZINE SODIUM |
21981 | A | II | 9/8/2008 | CORDEN PHARMA BERGAMO SPA | OLSALAZINE SODIUM |
27618 | A | II | 12/27/2013 | EMCURE PHARMACEUTICALS LTD | OLSALAZINE SODIUM (PROCESS II) |
6443 | I | II | 6/23/1986 | PHARMACIA AND UPJOHN | OLSALAZINE SODIUM |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information